Navigation Links
Grant to explore nanotech anti-infective agent for soldiers' wounds
Date:10/12/2010

ANN ARBOR, Mich. The U.S. Department of Defense has awarded $1.5 million over three years to the Michigan Nanotechnology Institute for Medicine and Biological Sciences and to Ann Arbor-based NanoBio Corporation to develop and test nanoemulsions with potential to fight a wide range of wound infections, including drug-resistant forms.

Soldiers in Iraq and Afghanistan get infections, sometimes life-threatening, from shrapnel wounds, IED blast injuries and burns. Bacteria from soil, air and a soldier's skin can enter wounds on the battlefield. A treatment easily applied in battle zones and in hospitals that is broadly effective against bacteria, viruses and fungi would help reduce these infections.

Present therapies aren't effective enough against antibiotic-resistant strains of bacteria, and don't prevent or control a problem soldiers with severe burns encounter: They may fall victim to long-lasting inflammatory responses that delay healing.

"A broadly effective nanoemulsion-based wound treatment that can be safely and easily applied at the time of injury, without causing pain or interfering with wound healing, would have great value to prevent infection, increase survival and enable more rapid healing of wounded United States military personnel," says James R. Baker Jr., M.D., the principal investigator for the grant.

Baker directs the Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS) at U-M. He is the Ruth Dow Doan Professor of Nanotechnology and allergy division chief at the U-M Medical School and is founder and CEO of NanoBio Corporation.

Nanoemulsions are made of soybean oil, alcohol, water and surfactants emulsified into droplets 200 to 600 nanometers in diameter. They have proved effective at killing a variety of bacteria, fungi and viruses in previous research.

The U-M Nanotechnology Institute and NanoBio will use the grant to develop 10 new formulations of nanoemulsions against bacteria, fungi and spores in lab culture studies, followed by animal studies for effectiveness and safety. If successful, the resulting nanoemulsion treatment would proceed to human trials.

The grant allows U-M and NanoBio scientists to investigate another promising application for nanoemulsion technology developed by Baker with Department of Defense funds in the 1990s. Uses for nanoemulsions include treatments for cold sores, now in phase 3 clinical trials, and for toenail fungus and cystic fibrosis infections, as well as vaccines against influenza and bioterrorism agents.

In a study published earlier this year, U-M researchers found that a nanoemulsion lotion used to treat burns in animals was able to reduce bacterial growth one-thousand-fold compared to control animals receiving no treatment or a placebo. The nanoemulsion also reduced inflammation processes that can cause burn injuries to worsen.


'/>"/>

Contact: Anne Rueter
arueter@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related biology news :

1. Exciting new companies at NJITs small biz incubator get 100K in grants
2. Broad Institute awarded major grant to bolster epigenomics research
3. Entertainment Software Association Foundation awards grant to FAS for immune attack
4. National Science Foundation grants Clemson professors award to develop nanoprobes
5. Dunn Foundation gives Rice $3M for collaborative research grants
6. National Science Foundation grant expands UMCES oyster research
7. Penn State receives new NASA astrobiology grant
8. BIO-key(R) Granted Additional Patent for Biometric Security Solution
9. FSU researchers discovery leads to $1.5 million grant, potential new treatment of liver fibrosis
10. Northwest climate change is target of $3.2M in grants to University of Oregon
11. UT Southwestern researcher awarded Gates Foundation grant for novel vaccine development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/14/2016)... http://www.apimages.com ) - ... - Renvoi : image disponible via AP Images ( ... --> DERMALOG, le leader de l,innovation ... d,empreintes digitales pour l,enregistrement des réfugiés en Allemagne. ... produire des cartes d,identité aux réfugiés. DERMALOG dévoilera ...
(Date:3/11/2016)... 2016 --> ... "Image Recognition Market by Technology (Pattern Recognition), by Component ... Deployment Type (On-Premises and Cloud), by Industry Vertical and ... MarketsandMarkets, the global market is expected to grow from ... by 2020, at a CAGR of 19.1%. ...
(Date:3/10/2016)... BLUE BELL, Pa. , March 10, 2016   ... U.S. Customs and Border Protection (CBP) is testing ... in San Diego to help identify ... United States . The test, designed to help determine ... outdoor, pedestrian environment, began in February and will run until ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... 2016 NanoStruck Technologies Inc. ... ( Frankfurt : 8NSK) gibt bekannt, ... 13. August 2015 die Genehmigung von der CNSX ... 200.000.000 Einheiten auf 400.000.000 Einheiten zu erhöhen, um ... wurden 157.900.000 Einheiten mit dem ersten Teil der ...
(Date:4/27/2016)... ... April 27, 2016 , ... ... its Scientific Advisory Board. Dr. Lamka will assist PathSensors in expanding the use ... , PathSensors deploys the CANARY® test platform for the detection of harmful pathogens, ...
(Date:4/27/2016)... PARIS , April 27, 2016 ... system disorders, today announces the appointment of Catherine Moukheibir as ... succeed MedDay,s previous Chairman, Jean Jacques Garaud , who ... The change is effective immediately. Catherine started her ... Boston and London .  She ...
(Date:4/26/2016)... ... April 26, 2016 , ... The European Patent Office (EPO) ... of three finalists for the European Inventor Award 2016 in the category "Non-European countries." ... announced at a ceremony in Lisbon on June 9th. , The human capacity to ...
Breaking Biology Technology: